Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AdvaMed attrition

This article was originally published in The Gray Sheet

Executive Summary

VP-Federal Government Relations Jim Smith will join the American Health Care Association as senior VP on Aug. 9 after four years of service with the device trade group. His departure continues a marked turnover in AdvaMed management, which has seen former Exec VP-Federal Government Relations Steve Ubl and VP-Public Affairs Lisa Wolfington leave to form their own consultancies. Other recent losses include AdvaMed's MTLI Executive Director Nancy Singer to an exec recruiting firm and VP-Global Strategy & Analysis Marjory Searing to Pfizer. Searing recently was replaced by former Assistant U.S. Trade Representative Ralph Ives (1"The Gray Sheet" July 19, 2004, p. 24). Associate VP-Federal Government Relations Steve Tilton, who came to AdvaMed in June 2003 from the House Energy & Commerce Committee, is expected to join the list of staff departures shortly...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020673

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel